Gregory Conn

Chief Tech/Sci/R&D Officer at PDS BIOTECHNOLOGY CORPORATION

Net worth: 108 882 $ as of 2026-06-29

71 year

Health Technology

Consumer Services

Profile

Gregory L.
Conn is the founder of PDS Operating Corp.
Dr. Conn is Chief Scientific Officer at PDS Biotechnology Corp.
since 2005.
Dr. Conn was Director of the Process Development Department at Covance Biotechnology Services, Inc. from 1998 to 2000.
Dr. Conn completed graduate and doctorate degrees at Albert Einstein College of Medicine, Inc.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
PDS BIOTECHNOLOGY CORP. 0.22%	2026-01-11	123,589 ( 0.22% )	108 882 $	2026-06-29

Gregory Conn active positions

Companies	Position	Start
PDS BIOTECHNOLOGY CORPORATION	Chief Tech/Sci/R&D Officer	2004-12-31

All active positions of Gregory Conn

Former positions of Gregory Conn

Companies	Position	End
Covance Biotechnology Services, Inc. Covance Biotechnology Services, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products	Corporate Officer/Principal	1999-12-31
PDS Operating Corp. PDS Operating Corp. Pharmaceuticals: MajorHealth Technology Develops novel cancer immunotherapies and vaccines for infectious disease	Founder	-

See the detail of Gregory Conn's experience

Training of Gregory Conn

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Gregory Conn's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
PDS Operating Corp. PDS Operating Corp. Pharmaceuticals: MajorHealth Technology Develops novel cancer immunotherapies and vaccines for infectious disease	Health Technology
Covance Biotechnology Services, Inc. Covance Biotechnology Services, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products	Health Technology
Albert Einstein College of Medicine, Inc. Albert Einstein College of Medicine, Inc. Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
PDS Biotechnology Corp. PDS Biotechnology Corp. Pharmaceuticals: MajorHealth Technology Develops clinical-stage immunotherapies to treat various early-stage and late-stage cancers which includes head & neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer and related cancers	Health Technology